Journal profile · Oncology
Seminars in Oncology
ISSN 0093-7754 · eISSN 1532-8708 · W.B. Saunders Ltd · UNITED STATES · Bimonthly · Founded 1974
Seminars in Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 6.61; hybrid open access; APC about USD 3,550; median 100 days to acceptance (102 articles, last 24 months); community-reported acceptance: moderate; 96 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Seminars in Oncology is published by W.B. Saunders Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations and Diverse Scientific and Economic Studies, together about 21% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Yuqing ZhangPublisher website
Editorial board by country: 5 in mainland China (about 31%); most named United States 11, Mainland China 5 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Treatment and PharmacologyMedicine7.2%
- Lung Cancer Treatments and MutationsMedicine7.1%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.7%
- Colorectal Cancer Treatments and StudiesMedicine5.6%
- HER2/EGFR in Cancer ResearchMedicine5.2%
- Lung Cancer Research StudiesMedicine5%
- Human auditory perception and evaluationEngineering4.8%
- Lymphoma Diagnosis and TreatmentMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.61LetPub ·
- Impact factor (publisher)
- 6.8Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- CiteScore (publisher)
- 4.9Publisher website ·
- SJR 2026-06
- 1.54LetPub ·
- SNIP 2026-06
- 1.09LetPub ·
- h-index
- 125LetPub ·
- h-index
- 149OpenAlex ·
- i10-index
- 2,137OpenAlex ·
- 2-year mean citedness
- 2.84OpenAlex ·
- Self-citation rate
- 8.8%LetPub ·
- Share of gold OA articles
- 19.47%LetPub ·
Volume
- Articles per year
- 75LetPub ·
Articles by year OpenAlex count · 4,240 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 62 | 18 | 16 |
| 2025 | 96 | 17 | 387 |
| 2024 | 31 | 10 | 133 |
| 2023 | 38 | 10 | 437 |
| 2022 | 78 | 17 | 603 |
| 2021 | 52 | 21 | 1,021 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
100 daysMedian, submission to acceptance · P25–P75 68 days – 144 days
- Acceptance to online
- median 9 days (102 articles)
- Submission to online
- median 124 days
- Sample
- 102 articles with submission and acceptance dates (125 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- First decision after review
- 36 daysPublisher website ·
- Submission to acceptance
- 86 daysPublisher website ·
- Acceptance to publication
- 33 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,550 / EUR 3,320 / GBP 2,840 / JPY 440,310 | — | — | |
| Publisher website | USD 3,900 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
Article types accepted14, with length limits
- case reportReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…main text ≤ 3,000 words
- case reportsCase Reports are peer reviewed, limited to 3,000 words, and may include up to five display items (figures, tables, or videos).Length not stated
- consensus statements and guidelinesGuidelines and Consensuses Statements are peer-reviewed. Submissions should contain a maximum of 6,000 words (excluding the abstract, references, figures, and t…Length not stated
- letters to the editorReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…Length not stated
- mini reviewmay include up to 6 figures and tables. Mini Reviews Mini reviews should have 3000-3500 words, with appropriate reductions for one or two figures or tablmain text ≤ 3,500 words
- mini reviewsMini reviews should have 3000-3500 words, with appropriate reductions for one or two figures or tables, and should include a brief abstract, an introduction, a …Length not stated
- original articleReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…Length not stated
- original research articleReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…Length not stated
- perspectiveReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…Length not stated
- research articlesHigh-quality original research articles related to the latest trends and advances, covering all aspects of oncology and cancer research. The maximum text amount…Length not stated
- reviewReview ArticlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excl…main text ≤ 6,000 words
- review articlesReview articles are usually solicited. However, the Journal occasionally publishes unsolicited reviews. Reviews should not exceed 6000 words excluding reference…Length not stated
- short communicationuires an abstract maximum of 350 words. Short Communications Short communications should not exceed 3000 words excluding references; they may contain up to 3 fi…main text ≤ 3,000 words
- short communicationsShort communications should not exceed 3000 words excluding references; they may contain up to 3 figures or tables.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1974
- ISSN
- 0093-7754
- Electronic ISSN
- 1532-8708
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Oncology
What CAS zone is Seminars in Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Oncology?
The latest impact factor listed by LetPub is 6.61; CiteScore 4.9, h-index 149.
How long does peer review take at Seminars in Oncology?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 68–144 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Seminars in Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Seminars in Oncology based?
Of the 16 board members whose country the journal's board page names, 5 (about 31%) are in mainland China; the countries named most often are United States (11) and Mainland China (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Oncology?
According to LetPub and DOAJ records, Seminars in Oncology is indexed in SCIE and Scopus.
Is Seminars in Oncology open access, and what is the APC?
Seminars in Oncology is a hybrid journal. For open-access publication: APC about USD 3,550.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .